FxWirePro: Swiss Franc Losses Momentary, Macros To Reinstate Safe-Haven Sentiments – Quick Glance At EUR/CHF Short Trades
Donald Trump says ‘states should open up ASAP’ even as coronavirus death toll reaches more than 100,000
FxWirePro: Mexican Peso Likely To Underperform – Bid 3m Skews Ans Uphold USD/MXN Call Spreads To Hedge
Blockchain Revolution Series: Tencent Holdings To Invest Huge For Tech-Infra Including Blockchain, AI & Cyber Security
FxWirePro: Bearish/Bullish Driving Forces of EUR/USD, OTC Indications And Options Strategy Ahead of Eurozone PMIs
Aiming for novelty in coronavirus coverage, journalists end up sensationalizing the trivial and untrue
Beijing refutes Donald Trump’s allegation that the ‘incompetence of China’ contributed to the high coronavirus death toll worldwide
Donald Trump’s plan of reopening the economy could mean the ‘death sentence’ for many Americans, says health expert
Cryptocurrency Derivatives Series: Block-Halving & Open Interest Factors Drive Bitcoin Price To $10k Trajectory, Long Hedges Intact
High-dose, immune-boosting or four-strain? A guide to flu vaccines for over-65s
Flu vaccines work by exposing the body to a component of the virus so it can “practise” fighting it off, without risking infection. The immune system can then mount a more rapid and effective response when faced with a “real” virus.
Three types of influenza vaccines are available in Australia:
“standard” vaccines that contains four different strains of influenza
a “high-dose” vaccine (Fluzone High Dose) that contains three strains of influenza at a higher dose than standard vaccines
an “adjuvanted” vaccine (Fluad) that contains the standard dose of three strains of influenza, along with MF59, an immune stimulant designed to encourage a stronger immune response to the vaccine.
The high-dose and adjuvanted vaccines are designed for use only in people aged 65 and over because they can stimulate a better immune response than the standard vaccine. Standard vaccines should be used those younger than 65 years.
This year, the Australian government is offering the adjuvanted vaccine for free for over-65s. The standard vaccine is available for free for some groups under 65 under national and state programs. The high-dose vaccine will only be available to buy through pharmacies and general practices on prescription.
Is the high-dose vaccine better?
Clinical trials have compared the high-dose vaccine with older forms of the standard vaccine that contained three strains.
One US study in over-65s found 1.4% of recipients who were given the high-dose vaccine were diagnosed with influenza, compared with 1.9% of those who received the standard vaccine.
Subsequent studies also found people who got the high-dose vaccine were less likely to be hospitalised with influenza-related complications. A similar trial in nursing home residents also found a reduced risk of hospitalisation.
Although clinical trials are generally regarded as the gold standard when testing vaccines, it’s also important to consider data from other studies, where different flu strains circulate and where the vaccine may be used in groups that were excluded from clinical trials.
What about the adjuvanted vaccine?
Clinical trials have not been designed to show the different rates of flu infection after taking the adjuvanted vaccine compared with the standard vaccine. But studies have examined the effectiveness of this vaccine in preventing hospitalisations with influenza.
One trial found a small decrease in influenza infection in people who had been given adjuvanted vaccine, compared with standard vaccine, but this difference was not statistically significant.
Another recent trial has been performed in nursing home residents. Preliminary results suggest a very small reduction in hospitalisations compared with those who took the standard vaccine.
Despite a lack of clinical trial data, several observational studies have found getting the adjuvanated vaccine means you’re less likely to be hospitalised with influenza than if you receive the standard vaccine.
As with the studies of the high-dose vaccine, the estimated degree of protection varies between studies, reflecting differences in circulating strains, study types, and populations.
Which is better?
There is not yet sufficient data to know whether one enhanced vaccine is better than the other.
One observational study suggests the high-dose vaccine is more effective than the adjuvanted vaccine at preventing hospital admissions with influenza. But this study was not designed to address this question specifically, and the differences observed were small.
Both enhanced vaccines are safe. Although a higher proportion of patients who receive enhanced vaccines report a sore arm, compared to those who receive the standard vaccine, this is generally mild and rarely requires medical attention.
Can you get two for better coverage?
The currently available enhanced vaccines protect against three flu strains, whereas the standard vaccine protects against four.
But for most people, there is no evidence that receiving multiple doses of different vaccines in any one year is any better than getting a single dose of vaccine.
There’s no evidence that two shots are better than one. By Nyvlt-art
In theory, the four-strain vaccines protect against one more strain than the enhanced three-strain vaccines. But in most seasons, few infections are caused by the fourth strain.
There are some specific groups of people for whom two doses may be recommended, including young children receiving the vaccine for the first time, and some people with bone marrow or organ transplants. Seek advice from your doctor if this describes you or your children’s situation.
It’s important to note that none of the standard or enhanced flu vaccines are completely protective; they reduce, but don’t completely eliminate, the risk of getting influenza.
A single dose of any influenza vaccine in each season is the most effective strategy to reduce your chance of getting influenza.